“…The forkhead box transcription factor C2 (Foxc2) is expressed during embryonic development in the presomitic and paraxial mesoderm (Miura et al, 1993;Winnier et al, 1997), in the endothelium of the pharyngeal arch arteries, outflow tract, and ventricles, and in cardiac neural crest cells that colonize the pharyngeal arches and outflow tract (Iida et al, 1997;Winnier et al, 1999;Seo et al, 2006). More recently, our lineage tracing analyses of Foxc2 expressing cardiac neural crest cells revealed that these cells additionally contribute to the aorta, pulmonary trunk, valves, and endocardial cushions (Amin et al, 2017). Furthermore, studies in mice have indicated that Foxc2 is expressed in, and plays a critical role in proper development of lymphatic vessels and valves (Dagenais et al, 2004;Petrova et al, 2004;Seo et al, 2006;Sabine et al, 2012), and consistent with these observations, heterozygous mutations in FOXC2 are associated with congenital lymphedema distichiasis in humans (Sutkowska et al, 2012).…”